Suchergebnisse - "Baldwin, David R"

PubPharm (185)

1

Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context

enthalten in: bioRxiv.org | 2024

von Quinn-Scoggins, H. | Murray, R. | Quaife, S. | +8

2

Current and Future Perspectives on Computed Tomography Screening for Lung Cancer : A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Lam, S. | Bai, C. | Baldwin, D. | +17

3

Determining the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT (DOLCE) study protocol : a prospective, non-interventional multicentre UK study

enthalten in: BMJ open | 2024

von O'Dowd, E. | Berovic, M. | Callister, M. | +24

4

Cost-effectiveness of volume computed tomography in lung cancer screening : a cohort simulation based on Nelson study outcomes

enthalten in: Journal of medical economics | 2024

von Pan, X. | Dvortsin, E. | Baldwin, D. | +7

5

ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer

enthalten in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery | 2023

von O'Dowd, E. | Tietzova, I. | Bartlett, E. | +30

6

ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer

enthalten in: The European respiratory journal | 2023

von O'Dowd, E. | Tietzova, I. | Bartlett, E. | +30

ErratumIn: Eur Respir J. 2024 Feb 1;63(2):. - PMID 38302184

7

ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer

enthalten in: European journal of cardio-thoracic surgery | October 2023

von O'Dowd, E. | Tietzova, I. | Bartlett, E. | +30

8

Clinical trials in cancer screening, prevention and early diagnosis (SPED) : a systematic mapping review

enthalten in: BMC cancer | 2023

von O'Dowd, E. | Merriel, S. | Cheng, V. | +10

9

Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review

enthalten in: BMC cancer | 2023

von O’Dowd, E. | Merriel, S. | Cheng, V. | +10

10

Predicting the future risk of lung cancer : development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models

enthalten in: The Lancet. Respiratory medicine | 2023

von Liao, W. | Coupland, C. | Burchardt, J. | +31

CommentIn: Lancet Respir Med. 2023 Aug;11(8):665-666. - PMID 37030306

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]